News & Updates

Arsenic exposure in drinking water, even at high levels, does not appear to contribute to an increased risk of prostate cancer, according to a case–control study.

Individuals with end-stage kidney disease (ESKD) who have mild-to-severe constipation obtain relief from tenapanor in the post hoc analysis of the phase III BLOCK study.

New drug applications approved by US FDA as of 16-31 October 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.

Perioperative antifungal prophylaxis appears to reduce the risk of infection in patients undergoing inflatable penile prosthesis surgery, suggests a study.

Nearly half of the children who require hypospadias repair need further corrective procedures, normally before the age of five, with low rates of penile reoperations in the second and third decades of life, reports a recent study.

Gay men and bisexual individuals are more likely to have risky sexual behaviours and experience sexual victimization, sexual dysfunctions, and other adverse outcomes than lesbians, reports a Danish study.

In the post hoc analysis of the phase III PROTECT trial, the non-immunosuppressive dual endothelin angiotensin receptor antagonist sparsentan remains superior to irbesartan for the treatment of immunoglobulin A nephropathy (IgAN).

Capsule 500 mcg/400 mcg